Complete Filing Data
Envoy Medical, Inc. reported Stockholders Equity of -$12.16 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Envoy Medical, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$23.8M | -$20.8M | -$29.9M | -$15.9M | -$251.6K | -$701.00 |
| Operating Income Loss | -$22.3M | -$19.3M | -$18.4M | -$8.7M | -$5.2M | -$701.00 |
| Nonoperating Income Expense | -$1.5M | -$1.5M | -$11.6M | -$7.2M | ||
| Revenues | $241.0K | $225.0K | $316.0K | $237.0K | ||
| Research And Development Expense | $12.5M | $10.2M | $9.0M | $5.0M | ||
| Net Income Loss Available To Common Stockholders Basic | -$28.7M | -$28.0M | -$31.3M | -$15.9M | ||
| Net Income Loss Available To Common Stockholders Diluted | -$28.7M | -$28.0M | -$31.3M | -$15.9M | ||
| Other Nonoperating Income Expense | -$23.0K | -$26.0K | $54.0K | -$127.0K | ||
| Cost Of Goods And Services Sold | $874.0K | $742.0K | $789.0K | $498.0K | ||
| Comprehensive Income Net Of Tax | -$23.8M | -$20.8M | -$29.9M | -$15.9M | ||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $3.0K | -$5.0K | -$3.0K | |||
| General And Administrative Expense | $7.9M | $6.8M | $7.3M | |||
| Selling And Marketing Expense | $1.2M | $1.7M | $1.7M | $885.0K | ||
| Other Comprehensive Income Loss Net Of Tax | $3.0K | -$5.0K | -$3.0K | |||
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | -$3.0K | -$7.0K | ||||
| Interest Expense Nonoperating | $1.6M | $816.0K | ||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $20.7M | -$251.6K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$6.5M | -$5.7M | -$5.0M | -$6.0M | -$3.9M | -$6.3M | $1.6M | -$13.3M | -$13.3M | -$1.3M | -$1.2M | -$1.9M | $5.6M | $371.1K | -$1.5M |
| Operating Income Loss | -$5.7M | -$5.1M | -$5.1M | -$5.0M | -$4.9M | -$4.9M | -$3.4M | -$4.5M | -$3.8M | -$1.8M | -$901.4K | -$1.5M | -$3.0M | -$1.1M | -$966.3K |
| Nonoperating Income Expense | -$774.0K | -$620.0K | $109.0K | -$988.0K | $905.0K | -$1.4M | $4.9M | -$8.8M | -$9.5M | $457.0K | -$504.2K | ||||
| Revenues | $42.0K | $78.0K | $46.0K | $56.0K | $68.0K | $59.0K | $80.0K | $63.0K | $78.0K | $57.0K | |||||
| Research And Development Expense | $2.7M | $2.5M | $2.7M | $2.8M | $2.6M | $2.4M | $1.9M | $2.2M | $1.9M | $935.0K | |||||
| Net Income Loss Available To Common Stockholders Basic | -$7.7M | -$6.9M | -$6.2M | -$7.3M | -$5.3M | -$7.6M | $1.4M | -$13.2M | -$13.3M | -$1.3M | |||||
| Net Income Loss Available To Common Stockholders Diluted | -$7.7M | -$6.9M | -$6.2M | -$7.3M | -$5.3M | -$7.6M | $1.4M | -$13.2M | -$13.3M | -$1.3M | |||||
| Other Nonoperating Income Expense | $5.0K | -$1.0K | -$11.0K | $13.0K | -$8.0K | -$14.0K | $46.0K | -$117.0K | |||||||
| Cost Of Goods And Services Sold | $203.0K | $234.0K | $226.0K | $187.0K | $245.0K | $153.0K | $189.0K | $162.0K | $175.0K | $106.0K | |||||
| Comprehensive Income Net Of Tax | -$6.5M | -$5.7M | -$5.0M | -$6.0M | -$3.9M | -$6.3M | $1.6M | -$13.2M | -$13.3M | -$1.3M | |||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$1.0K | -$2.0K | $6.0K | -$1.0K | -$1.0K | -$1.0K | -$1.0K | -$1.0K | |||||||
| General And Administrative Expense | $2.4M | $2.1M | $1.8M | $1.7M | $1.6M | $2.1M | $1.0M | $1.8M | $1.4M | ||||||
| Selling And Marketing Expense | $405.0K | $361.0K | $358.0K | $394.0K | $497.0K | $325.0K | $399.0K | $383.0K | $371.0K | ||||||
| Other Comprehensive Income Loss Net Of Tax | -$1.0K | -$2.0K | $6.0K | -$1.0K | -$1.0K | -$1.0K | -$1.0K | -$1.0K | |||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | -$1.0K | -$1.0K | -$1.0K | $1.0K | -$3.0K | -$2.0K | $2.0K | ||||||||
| Interest Expense Nonoperating | $471.0K | $624.0K | $495.0K | $264.0K | $132.0K | $36.0K | |||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$1.0M | $1.6M | $6.2M | $3.2M | $12.5M | $5.6M | $371.1K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity | -$12.2M | -$18.8M | -$1.8M | -$36.2M | -$45.0M | $24.3K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $3.7M | $5.5M | $4.2M | $183.0K | $1.1M | $25.0K |
| Retained Earnings Accumulated Deficit | -$313.4M | -$284.7M | -$226.0M | -$36.7M | -$701.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.7M | $1.3M | $4.0M | -$938.0K | $124.8K | $25.0K |
| Liabilities Current | $11.6M | $7.5M | $7.3M | $2.5M | $2.7M | $95.7K |
| Liabilities And Stockholders Equity | $8.6M | $11.5M | $8.3M | $2.6M | $426.9M | $120.0K |
| Liabilities | $20.3M | $30.4M | $10.0M | $38.8M | $38.6M | $95.7K |
| Assets | $8.6M | $11.5M | $8.3M | $2.6M | $426.9M | $120.0K |
| Accounts Payable Current | $2.9M | $1.7M | $1.6M | $1.0M | $618.7K | $95.7K |
| Assets Current | $6.3M | $8.9M | $7.5M | $1.6M | $863.2K | $25.0K |
| Accrued Liabilities Current | $7.6M | $3.7M | $4.6M | $608.0K | $2.1M | |
| Dividends Preferred Stock | $4.9M | $5.5M | $1.3M | |||
| Change In Fair Value Of Publicly Traded Warrant Liability | -$111.0K | $330.0K | -$942.0K | |||
| Cash And Cash Equivalents At Carrying Value | $4.2M | $183.0K | $149.8K | $25.0K | ||
| Property Plant And Equipment Net | $1.0M | $1.3M | $351.0K | $331.0K | ||
| Inventory Net | $1.5M | $1.7M | $1.4M | $1.3M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$120.0K | -$123.0K | -$118.0K | -$115.0K | ||
| Inventory LIFO Reserve Period Charge | $36.0K | $76.0K | -$99.0K | -$41.0K | ||
| Change In Operating Lease Rightofuse Assetsrelated Party | $206.0K | $113.0K | $113.0K | $119.0K | ||
| Prepaid Expense And Other Assets Current | $941.0K | $887.0K | $1.6M | $129.0K | ||
| Accounts Receivable Net Current | $34.0K | $38.0K | $70.0K | $41.0K | ||
| Temporary Equity Carrying Amount Attributable To Parent | $391.0K | $425.0M | ||||
| Other Receivables Net Current | $19.0K | $780.0K | $176.0K | |||
| Dividends Preferred Stock Cash | $4.9M | $5.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$7.7M | -$29.9M | -$24.2M | -$18.5M | -$12.4M | -$7.4M | $4.8M | -$45.1M | -$47.5M | -$25.5M | -$26.2M | -$25.6M | -$32.8M | -$38.3M | -$38.3M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $3.6M | $5.3M | $5.3M | $4.4M | $1.7M | $4.9M | $16.8M | $68.0K | $1.1M | $609.0K | $476.9K | $127.1K | $1.0M | $1.7M | $2.2M | ||
| Retained Earnings Accumulated Deficit | -$305.7M | -$297.9M | -$291.0M | -$277.5M | -$270.2M | -$264.9M | -$257.3M | -$251.0M | -$20.8M | -$19.2M | -$17.4M | -$21.5M | -$24.3M | -$32.8M | -$38.3M | -$38.3M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$171.0K | $727.0K | $931.0K | -$22.7K | $2.1M | ||||||||||||
| Liabilities Current | $9.0M | $8.0M | $7.6M | $9.1M | $8.1M | $7.0M | $13.6M | $9.3M | $9.5M | $6.0M | $5.3M | $4.0M | $2.8M | $670.6K | $96.4K | ||
| Liabilities And Stockholders Equity | $8.2M | $9.9M | $10.4M | $9.4M | $6.7M | $8.5M | $23.6M | $45.0M | $45.9M | $427.8M | $427.2M | $426.3M | $427.0M | $427.8M | $423.3M | ||
| Liabilities | $15.7M | $39.8M | $34.6M | $27.9M | $19.1M | $15.9M | $17.3M | $21.2M | $21.0M | $18.3M | $23.3M | $25.6M | $34.7M | $41.2M | $41.6M | ||
| Assets | $8.2M | $9.9M | $10.4M | $9.4M | $6.7M | $8.5M | $23.6M | $45.0M | $45.9M | $427.8M | $427.2M | $426.3M | $427.0M | $427.8M | $423.3M | ||
| Accounts Payable Current | $2.7M | $1.6M | $1.7M | $1.8M | $1.6M | $913.0K | $3.4M | $1.4M | $1.6M | $1.1M | $884.6K | $658.9K | $800.1K | $56.9K | |||
| Assets Current | $5.8M | $7.5M | $8.3M | $7.1M | $5.0M | $7.7M | $22.7M | $397.7K | $516.9K | $590.2K | $940.7K | $744.3K | $1.9M | $2.8M | $3.3M | ||
| Accrued Liabilities Current | $5.9M | $4.7M | $5.1M | $6.9M | $6.0M | $5.6M | $4.1M | $5.1M | $5.5M | $3.0M | $2.8M | $2.6M | $2.0M | $428.2K | |||
| Dividends Preferred Stock | $1.3M | $1.3M | $1.2M | $1.4M | $1.4M | $1.4M | |||||||||||
| Change In Fair Value Of Publicly Traded Warrant Liability | $33.0K | $32.0K | -$194.0K | $426.0K | -$801.0K | $1.2M | |||||||||||
| Cash And Cash Equivalents At Carrying Value | $7.4M | $132.8K | $104.0K | $302.0K | $476.9K | $127.1K | $1.0M | $1.7M | $2.2M | ||||||||
| Property Plant And Equipment Net | $1.1M | $1.1M | $1.2M | $1.2M | $632.0K | $317.0K | $378.0K | ||||||||||
| Inventory Net | $1.6M | $1.6M | $1.7M | $1.6M | $1.6M | $1.5M | $1.4M | ||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$120.0K | -$119.0K | -$117.0K | -$121.0K | -$120.0K | -$119.0K | -$116.0K | ||||||||||
| Inventory LIFO Reserve Period Charge | -$23.0K | $89.0K | -$14.0K | ||||||||||||||
| Change In Operating Lease Rightofuse Assetsrelated Party | $26.0K | $31.0K | $22.0K | ||||||||||||||
| Prepaid Expense And Other Assets Current | $508.0K | $576.0K | $1.3M | $842.0K | $1.5M | $1.1M | $997.0K | ||||||||||
| Accounts Receivable Net Current | $35.0K | $43.0K | $42.0K | $197.0K | $174.0K | $189.0K | $109.0K | ||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $130.0K | $44.6M | $44.2M | $429.7M | $426.9M | $425.3M | $425.0M | $425.0M | $425.0M | $420.0M | |||||||
| Other Receivables Net Current | $19.0K | $20.0K | $23.0K | $32.0K | $28.0K | $32.0K | $1.0M | ||||||||||
| Dividends Preferred Stock Cash | $1.3M | $1.3M | $1.2M | $1.4M | $1.4M | $1.4M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share-Based Compensation * | $657.0K | $562.0K | $1.6M | $0.00 | ||
| Net Cash Provided By Used In Operating Activities | -$18.2M | -$17.9M | -$17.1M | -$8.8M | -$3.2M | $0.00 |
| Net Cash Provided By Used In Financing Activities | $16.6M | $20.2M | $21.3M | $8.1M | $428.4M | $25.0K |
| Increase Decrease In Accounts Payable | $1.4M | -$19.0K | $551.0K | $342.0K | $618.0K | $0.00 |
| Increase Decrease In Accrued Liabilities | $839.0K | -$241.0K | -$94.0K | $133.0K | $2.1M | $701.00 |
| Net Cash Provided By Used In Investing Activities | -$179.0K | -$980.0K | -$153.0K | -$218.0K | -$425.0M | $0.00 |
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $657.0K | $562.0K | $1.6M | |||
| Increase Decrease In Accounts Receivable | -$4.0K | -$32.0K | $29.0K | -$47.0K | ||
| Increase Decrease In Inventories | -$126.0K | $380.0K | $10.0K | $194.0K | ||
| Payments To Acquire Property Plant And Equipment | $179.0K | $980.0K | $153.0K | $218.0K | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $8.0K | -$9.0K | $853.0K | -$38.0K | ||
| Increase Decrease In Operating Lease Liability | -$239.0K | -$145.0K | -$128.0K | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $3.0K | -$5.0K | -$3.0K | -$7.0K | ||
| Increase Decrease In Derivative Liabilities | -$161.0K | -$181.0K | -$244.0K | |||
| Proceeds From Related Party Debt | $10.0M | $20.0M | $1.5M | |||
| Increase Decrease In Prepaid Expense | $104.2K | $1.2M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $160.0K | $123.0K | |||||||
| Net Cash Provided By Used In Operating Activities | -$3.7M | -$5.6M | -$3.0M | -$772.7K | -$1.2M | ||||
| Net Cash Provided By Used In Financing Activities | $3.6M | $6.4M | $4.0M | $750.0K | $423.4M | ||||
| Increase Decrease In Accounts Payable | $10.0K | -$641.0K | $1.0M | $40.2K | -$13.1K | ||||
| Increase Decrease In Accrued Liabilities | $199.0K | -$357.0K | -$180.0K | $580.0K | |||||
| Net Cash Provided By Used In Investing Activities | -$6.0K | -$109.0K | -$59.0K | -$420.0M | |||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $172.0K | $146.0K | $160.0K | $144.0K | $142.0K | $123.0K | |||
| Increase Decrease In Accounts Receivable | $4.0K | $119.0K | $22.0K | ||||||
| Increase Decrease In Inventories | -$74.0K | $140.0K | |||||||
| Payments To Acquire Property Plant And Equipment | $6.0K | $59.0K | |||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $75.0K | $56.0K | $37.0K | ||||||
| Increase Decrease In Operating Lease Liability | -$22.0K | -$27.0K | |||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $6.0K | -$1.0K | $1.0K | ||||||
| Increase Decrease In Derivative Liabilities | -$17.0K | -$6.0K | |||||||
| Proceeds From Related Party Debt | $5.0M | $5.0M | |||||||
| Increase Decrease In Prepaid Expense | $534.8K | $92.7K | $1.2M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Weighted Average Number Of Diluted Shares Outstanding | 23.3M | 18.8M | 12.3M | 10.1M | ||
| Earnings Per Share Diluted | $-1.23 | $-1.49 | $-2.54 | $-1.57 | ||
| Weighted Average Number Of Shares Outstanding Basic | 23.3M | 18.8M | 12.3M | 10.1M | ||
| Earnings Per Share Basic | $-1.23 | $-1.49 | $-2.54 | $-1.57 | ||
| Preferred Stock Shares Outstanding | 4.5M | 0.00 | 0.00 | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | ||||
| Preferred Stock Shares Authorized | 10.0M | 1.0M | 1.0M | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | ||||
| Common Stock Shares Outstanding | ||||||
| Temporary Equity Shares Outstanding | 42.5M | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Diluted Shares Outstanding | 21.9M | 21.4M | 21.3M | 18.6M | 18.6M | 18.6M | 11.2M | 10.1M | 10.1M | 10.1M | |||||||||
| Earnings Per Share Diluted | $-0.35 | $-0.32 | $-0.29 | $-0.39 | $-0.29 | $-0.41 | $0.13 | $-1.31 | $-1.31 | $-0.13 | |||||||||
| Weighted Average Number Of Shares Outstanding Basic | 21.9M | 21.4M | 21.3M | 18.6M | 18.6M | 18.6M | 10.2M | 10.1M | 10.1M | ||||||||||
| Earnings Per Share Basic | $-0.35 | $-0.32 | $-0.29 | $-0.39 | $-0.29 | $-0.41 | $0.13 | $-1.31 | $-0.13 | ||||||||||
| Preferred Stock Shares Outstanding | 4.1M | 4.1M | 4.1M | 4.1M | 4.5M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Preferred Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | |||||
| Preferred Stock Shares Issued | 4.1M | 4.1M | 4.1M | 100.0M | 100.0M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Common Stock Shares Outstanding | 21.5M | 21.3M | 21.3M | 18.7M | 18.6M | 18.6M | 18.6M | 19.5M | 12.1M | 0.00 | |||||||||
| Temporary Equity Shares Outstanding | 4.3M | 42.5M | 42.5M | 42.5M | 42.5M | 42.5M | 38.2M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | -$534.0K | -$411.0K | -$842.0K | -$20.0M | -$5.5M | $0.00 |
| Costs And Expenses | $22.5M | $19.5M | $18.7M | $8.9M | ||
| Depreciation | $302.0K | $173.0K | $133.0K | $75.0K | ||
| Additional Paid In Capital | $301.4M | $266.0M | $255.6M | $189.9M | $23.8K | |
| Adjustments To Additional Paid In Capital Other | $18.7M | $4.7M | ||||
| Adjustments To Additional Paid In Capital Warrant Issued | $1.6M | $1.4M | ||||
| Operating Costs And Expenses | $4.9M | $5.2M | $701.00 | |||
| Investment Income Interest | $6.1M | $37.7K | $0.00 | |||
| Fair Value Option Changes In Fair Value Gain Loss1 | $103.0K | -$69.0K | ||||
| Unrealized Gain Loss On Derivatives | -$13.3M | -$7.1M | ||||
| Change In Fair Value Of Forward Purchase Agreements | $649.1K | -$232.8K | ||||
| Warrants And Rights Outstanding | $24.0K | $472.0K | $4.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | -$64.0K | -$37.0K | -$421.0K | $311.0K | -$244.0K | $262.0K | $266.7K | -$1.3M | -$3.5M | -$14.4M | -$8.5M | -$1.4M | $512.0K | ||
| Costs And Expenses | $5.8M | $5.1M | $5.2M | $5.0M | $4.9M | $4.9M | $3.5M | $4.5M | $3.8M | $1.9M | |||||
| Depreciation | $76.0K | $61.0K | $49.0K | $34.0K | $27.0K | ||||||||||
| Additional Paid In Capital | $298.1M | $268.2M | $266.9M | $259.1M | $257.9M | $257.6M | $257.4M | $6.1M | $6.5M | ||||||
| Adjustments To Additional Paid In Capital Other | $1.7M | $1.0M | $15.7M | $2.0M | $2.0M | $645.0K | $1.3M | ||||||||
| Adjustments To Additional Paid In Capital Warrant Issued | $882.0K | $688.0K | $699.0K | $197.0K | $179.0K | $782.8K | |||||||||
| Operating Costs And Expenses | $98.6K | $2.5M | $1.0M | $901.4K | $1.5M | $3.0M | $1.1M | $966.3K | |||||||
| Investment Income Interest | $528.3K | $3.4M | $1.9M | $563.4K | $40.4K | $5.5K | $15.4K | $7.8K | |||||||
| Fair Value Option Changes In Fair Value Gain Loss1 | $103.0K | ||||||||||||||
| Unrealized Gain Loss On Derivatives | $4.9M | -$9.4M | $574.0K | ||||||||||||
| Change In Fair Value Of Forward Purchase Agreements | $1.0M | -$681.5K | $470.1K | -$70.3K | $487.2K | ||||||||||
| Warrants And Rights Outstanding | $12.0K | $14.0K | $51.0K | $411.0K | $22.0K |
Most recent annual filing with the SEC: March 23, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.